TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
72 insider filings · Latest: Sep 19, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Mar 9 8:05 PM | Matthew ShieldsEVP, Global Operations | Sale | 17,295 | $31.67 | $547.7K | 9,989(D) | View → |
| Mar 4, 2026 | Mar 6 9:19 PM | Richard D FrancisPresident and CEO | Sale | 23,393 | $32.46 | $759.4K | 1,148,212(D) | View → |
| Mar 4, 2026 | Mar 6 9:17 PM | Richard DaniellEVP, Europe Commercial | Sale | 91,345 | $32.66 | $3.0M | 85,755(D) | View → |
| Mar 4, 2026 | Mar 6 9:09 PM | Eric A HughesSee "Remarks" | Sale | 11,277 | $32.46 | $366.1K | 97,590(D) | View → |
| Mar 4, 2026 | Mar 6 9:05 PM | Christine FoxEVP, U.S. Commercial | Sale | 9,098 | $32.46 | $295.4K | 75,010(D) | View → |
| Mar 4, 2026 | Mar 6 9:03 PM | Brian SavageInterim Chief Legal Officer | Sale | 2,675 | $32.46 | $86.8K | 8,461(D) | View → |
| Mar 5, 2026 | Mar 5 10:49 PM | Shields Matthew | Proposed Sale | 17,295 | $31.67 | $547.7K | — | View → |
| Mar 5, 2026 | Mar 5 10:43 PM | Jover Placid | Proposed Sale | 14,150 | $31.67 | $448.1K | — | View → |
| Mar 5, 2026 | Mar 5 10:39 PM | Savage Brian | Proposed Sale | 1,127 | $31.67 | $35.7K | — | View → |
| Mar 5, 2026 | Mar 5 10:32 PM | Fox Christine | Proposed Sale | 7,924 | $31.67 | $250.9K | — | View → |
| Mar 5, 2026 | Mar 5 10:26 PM | Francis Richard D | Proposed Sale | 20,025 | $31.67 | $634.2K | — | View → |
| Mar 5, 2026 | Mar 5 10:13 PM | Hughes Eric A | Proposed Sale | 9,533 | $31.67 | $301.9K | — | View → |
| Mar 5, 2026 | Mar 5 10:08 PM | Daniell Richard | Proposed Sale | 17,295 | $31.67 | $547.7K | — | View → |
| Mar 3, 2026 | Mar 5 9:09 PM | Richard DaniellEVP, Europe Commercial | Sale | 128,985 | $32.36 | $4.2M | 123,127(D) | View → |
| Mar 3, 2026 | Mar 5 9:06 PM | Brian SavageInterim Chief Legal Officer | Sale | 1,274 | $32.36 | $41.2K | 2,926(D) | View → |
| Mar 3, 2026 | Mar 5 9:05 PM | Richard D FrancisPresident and CEO | Sale | 442,935 | $32.36 | $14.3M | 1,121,382(D) | View → |
| Mar 3, 2026 | Mar 5 9:01 PM | Eric A HughesSee "Remarks" | Sale | 80,762 | $32.36 | $2.6M | 85,616(D) | View → |
| Mar 4, 2026 | Mar 4 10:42 PM | Fox Christine | Proposed Sale | 9,908 | $32.46 | $321.7K | — | View → |
| Mar 4, 2026 | Mar 4 10:36 PM | Francis Richard D | Proposed Sale | 23,393 | $32.46 | $759.4K | — | View → |
| Mar 4, 2026 | Mar 4 10:28 PM | Hughes Eric A | Proposed Sale | 11,277 | $32.46 | $366.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 28, 2026 | Jun 1 8:08 PM | Rosemary A CraneDirector | Grant/Award | 7,242 | — | 7,242(D) | View → |
| May 28, 2026 | Jun 1 8:06 PM | Chen LichtensteinDirector | Grant/Award | 7,242 | — | 7,242(D) | View → |
| May 28, 2026 | Jun 1 8:03 PM | BARER SOL JDirector | Grant/Award | 10,863 | — | 10,863(D) | View → |
| May 28, 2026 | Jun 1 8:02 PM | Roberto MignoneDirector | Grant/Award | 7,242 | — | 7,242(D) | View → |
| May 14, 2026 | May 18 8:02 PM | Evan LippmanEVP, Business Development | Option Exercise | 85,849 | — | 74,008(D) | View → |
| Mar 5, 2026 | Mar 9 8:23 PM | Mark SabagSee "Remarks" | Option Exercise | 15,723 | — | 47,170(D) | View → |
| Mar 5, 2026 | Mar 9 8:22 PM | Eliyahu Sharon KalifEVP, Chief Financial Officer | Option Exercise | 19,916 | — | 59,748(D) | View → |
| Mar 5, 2026 | Mar 9 8:19 PM | Amir WeissChief Accounting Officer | Option Exercise | 3,537 | — | 10,613(D) | View → |
| Mar 5, 2026 | Mar 9 8:18 PM | Richard D FrancisPresident and CEO | Option Exercise | 42,452 | — | 127,359(D) | View → |
| Mar 5, 2026 | Mar 9 8:16 PM | Christine FoxEVP, U.S. Commercial | Option Exercise | 17,819 | — | 53,459(D) | View → |
| Mar 5, 2026 | Mar 9 8:14 PM | Eric A HughesSee "Remarks" | Option Exercise | 19,654 | — | 58,962(D) | View → |
| Mar 5, 2026 | Mar 9 8:12 PM | Richard DaniellEVP, Europe Commercial | Option Exercise | 17,295 | — | 51,887(D) | View → |
| Mar 5, 2026 | Mar 9 8:10 PM | Placid JoverSee "Remarks" | Option Exercise | 14,150 | — | 42,453(D) | View → |
| Mar 5, 2026 | Mar 9 8:09 PM | Brian SavageInterim Chief Legal Officer | Option Exercise | 3,580 | — | 10,740(D) | View → |
| Mar 5, 2026 | Mar 9 8:05 PM | Matthew ShieldsEVP, Global Operations | Option Exercise | 17,295 | — | 51,887(D) | View → |
| Mar 4, 2026 | Mar 6 9:19 PM | Richard D FrancisPresident and CEO | Option Exercise | 50,223 | — | 100,446(D) | View → |
| Mar 4, 2026 | Mar 6 9:19 PM | Richard D FrancisPresident and CEO | Grant/Award | 136,736 | — | 136,736(D) | View → |
| Mar 4, 2026 | Mar 6 9:17 PM | Richard DaniellEVP, Europe Commercial | Option Exercise | 53,973 | — | 40,923(D) | View → |
| Mar 4, 2026 | Mar 6 9:17 PM | Richard DaniellEVP, Europe Commercial | Grant/Award | 33,424 | — | 33,424(D) | View → |
| Mar 4, 2026 | Mar 6 9:16 PM | Placid JoverSee "Remarks" | Grant/Award | 37,982 | — | 37,982(D) | View → |